Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: ANGELIQ
Active substances:
Estonian, English, Latin
ATC code: G03FA17
Dosage form: film-coated tablet
Strength: 2mg+1mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated February 16, 2024)
Package information leaflet (PIL): EST  (last updated February 16, 2024)
Labelling:  (last updated January 9, 2018)
Indication: Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women more than 1 year post menopause. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. (See also Section 4.4) The experience treating women older than 65 years is limited.
Safety features: Yes
Marketing authorization holder: Bayer AG 
Marketing authorization number: 472405 
Marketing authorization issued on: May 12, 2005 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1165711  ANGELIQ  film-coated tablet  2mg +1mg 28TK  Prescription  50% 100%    22.05.2024     
1165722  ANGELIQ  film-coated tablet  2mg +1mg 84TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere